Literature DB >> 7940926

Potential for CsA-Neoral in organ transplantation.

G Levy1, D Grant.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7940926

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.

Authors:  R Malekzadeh; S Nasseri-Moghaddam; M J Kaviani; H Taheri; N Kamalian; M Sotoudeh
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 3.  A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.

Authors:  S Friman; L Bäckman
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 4.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

5.  Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation.

Authors:  Stefano Federico; Rosa Carrano; Domenico Capone; Antonio Gentile; Giuseppe Palmiero; Vincenzo Basile
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 6.  Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

Authors:  S Noble; A Markham
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.